Tag

tutina

2 minuti di lettura

EirGenix’s Second Breast Cancer Biosimilar EG1206A Successfully Reaches Phase 1 Clinical Trial Objectives

(Adnkronos) – TAIPEI, May 3, 2023 /PRNewswire/ — EirGenix, Inc. (6589.TT) announced on 28th of April that it has completed the phase 1 clinical trial (EGC101) of its second breast cancer biosimilar EG1206A

>>> vai all'articolo completo

Immediapress

CGTN: How CPPCC proposals contribute to China’s policymaking

(Adnkronos) – BEIJING, March 4, 2023 /PRNewswire/ — In one proposal by members of the 13th National Committee of the Chinese People’s Political Consultative Conference (CPPCC), the country’s top political advisory body, efforts had been urged to consolidate poverty eradication

Former Head of Swiss Securities and Exchanges to head new Fintica AI Ltd Advisory Board

Immediapress

(Adnkronos) – New body to include industry experts: Thomas Zeeb, René Karsenti, Yanming Xiao TEL AVIV, Israel, April 13, 2023 /PRNewswire/ — Fintica AI